Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
08 2021
Historique:
received: 24 06 2020
accepted: 21 09 2020
pubmed: 18 10 2020
medline: 23 2 2022
entrez: 17 10 2020
Statut: ppublish

Résumé

A common side effect following radical prostatectomy is urinary incontinence. Here, we describe a novel surgical technique to reduce postoperative urinary incontinence and facilitate early return of continence. To describe the novel "hood technique" for robotic-assisted radical prostatectomy (RARP). This is an institutional review board-approved prospective study of 300 patients (median age 64 yr) with localized prostate cancer treated with the RARP hood technique at a major urban hospital between April 2018 and March 2019. The exclusion criteria were as follows: patients with anterior tumor location based on biopsy or multiparametric magnetic resonance imaging. All but one patient participated in follow-up over 12 mo after the procedure. The RARP "hood technique" was performed to preserve the detrusor apron, puboprostatic ligament complex, arcus tendineus, endopelvic fascia, and pouch of Douglas. Clinical data collected included pre- and intraoperative variables, and postoperative functional and oncological outcomes and complications. Descriptive statistical analysis was performed. Continence rates at 1, 2, 4, 6 12, 24, and 48 wk after catheter removal were 21%, 36%, 83%, 88%, 91%, 94%, and 95%, respectively. Positive surgical margin rate was 6%. Thirty patients (9.7%) experienced complications after RARP: 17 (5.7%), 11 (3.6%), and one (0.4%) had Clavien-Dindo grade I, II, and III complications, respectively. This study was conducted within a single health system and may not be generalizable. The study lacked randomization and a comparative arm. Results indicate that the hood technique spares musculofascial structures anterior to the urethral sphincter complex with early return of continence after surgery, without compromising positive surgical margin rates. Exclusion of anterior tumor location contributed to a reduction in positive surgical margins. By better preservation of anatomical structures around the urethra, we were able to achieve early return of urinary continence without a negative impact on complications and cancer outcomes.

Sections du résumé

BACKGROUND
A common side effect following radical prostatectomy is urinary incontinence. Here, we describe a novel surgical technique to reduce postoperative urinary incontinence and facilitate early return of continence.
OBJECTIVE
To describe the novel "hood technique" for robotic-assisted radical prostatectomy (RARP).
DESIGN, SETTING, AND PARTICIPANTS
This is an institutional review board-approved prospective study of 300 patients (median age 64 yr) with localized prostate cancer treated with the RARP hood technique at a major urban hospital between April 2018 and March 2019. The exclusion criteria were as follows: patients with anterior tumor location based on biopsy or multiparametric magnetic resonance imaging. All but one patient participated in follow-up over 12 mo after the procedure.
SURGICAL PROCEDURE
The RARP "hood technique" was performed to preserve the detrusor apron, puboprostatic ligament complex, arcus tendineus, endopelvic fascia, and pouch of Douglas.
MEASUREMENTS
Clinical data collected included pre- and intraoperative variables, and postoperative functional and oncological outcomes and complications. Descriptive statistical analysis was performed.
RESULTS AND LIMITATIONS
Continence rates at 1, 2, 4, 6 12, 24, and 48 wk after catheter removal were 21%, 36%, 83%, 88%, 91%, 94%, and 95%, respectively. Positive surgical margin rate was 6%. Thirty patients (9.7%) experienced complications after RARP: 17 (5.7%), 11 (3.6%), and one (0.4%) had Clavien-Dindo grade I, II, and III complications, respectively. This study was conducted within a single health system and may not be generalizable. The study lacked randomization and a comparative arm.
CONCLUSIONS
Results indicate that the hood technique spares musculofascial structures anterior to the urethral sphincter complex with early return of continence after surgery, without compromising positive surgical margin rates. Exclusion of anterior tumor location contributed to a reduction in positive surgical margins.
PATIENT SUMMARY
By better preservation of anatomical structures around the urethra, we were able to achieve early return of urinary continence without a negative impact on complications and cancer outcomes.

Identifiants

pubmed: 33067016
pii: S0302-2838(20)30771-5
doi: 10.1016/j.eururo.2020.09.044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-221

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published by Elsevier B.V.

Auteurs

Vinayak G Wagaskar (VG)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Electronic address: Vinayak.wagaskar@mountsinai.org.

Ankur Mittal (A)

Department of Urology, All India Institute of Medical Sciences, Rishikesh, India.

Stanislaw Sobotka (S)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Parita Ratnani (P)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Anna Lantz (A)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Ugo Giovanni Falagario (UG)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Alberto Martini (A)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Zach Dovey (Z)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Patrick-Julien Treacy (PJ)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Prachee Pathak (P)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Suit Nair (S)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Berryhill Roy (B)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Dimple Chakravarty (D)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Sara Lewis (S)

Department of Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Kenneth Haines (K)

Department of Pathology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Peter Wiklund (P)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Ash Tewari (A)

Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH